// App-Quantinova.ai

BSH2020‐PO‐208 : Reduced Intensity Conditioning with Thiotepa‐Fludarabine‐Busulphan (TBF) and Post‐Transplant Cyclophosphamide (PTC) Results in Rapid Complete Donor T‐cell Chimerism in Haploidentical Recipients with Acute Myeloid Leukaemia

Researchers

Presenter

  • R. Banerjee

Principal Investigators

  • N. Killeen

  • S. Toma

  • B. Rahman

  • R. Szydlo

  • J. Apperley

  • R. Palanicawandar

  • A. Pryce

  • E. Olavarria

  • J. Pavlu

  • A. Innes

Medical Centers

  • Centre for Haematology, Imperial College London, London,

  • Molecular Pathology Laboratory

  • Department of Haematology, Imperial College London,

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Calcitonin

  • Patched 1

  • Cluster of Differentiation 2AP

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • fludarabine tablet

  • Busulfex

  • Thiotepa

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved